# Joong‐Won Park

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/joong-won-park/

## Facts

| Field | Value |
| --- | --- |
| Citations | 55,444 |
| Field | Hepatocellular Carcinoma Treatment and Prognosis |
| h-index | 82 |
| i10-index | 187 |
| Last Known Institution | National Cancer Center |
| OpenAlex ID | https://openalex.org/A5011174725 |
| ORCID iD | https://orcid.org/0000-0001-9972-0494 |
| Works | 330 |

## Researcher papers

- [Global patterns of hepatocellular carcinoma management from diagnosis to death: the <scp>BRIDGE</scp> Study](https://scholariq.org/papers/global-patterns-of-hepatocellular-carcinoma-management-from-diagnosis-to-death/)
- [Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study](https://scholariq.org/papers/brivanib-versus-sorafenib-as-first-line-therapy-in-patients-with-unresectable/)

## Researcher topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Hepatitis B Virus Studies](https://scholariq.org/topics/hepatitis-b-virus-studies/)

## Researcher university

- [National Cancer Center](https://scholariq.org/institutions/national-cancer-center-2/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.